For citations:
Brkich G.E., Pyatigorskaya N.V., Zyryanov O.A., Demina N.B., Bakhrushina E.O., Krasnyuk I.I. Technologic Considerations of Creation Dosage Form of Original Substance 3,7-diazabicyclo[3.3.1]nonane. Drug development & registration. 2020;9(4):44-52. (In Russ.) https://doi.org/10.33380/2305-2066-2020-9-4-44-52
Email this article 